ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626880 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626880; 2) Community: the network communities that were significantly associated with the response to NSC 626880; 3) Molecule: the relationships between components within communities and NSC 626880; 4) MDR: the compounds that were significantly associated with the NSC 626880.

NSC Compound Enrichment Correlation
NSC 704886 2-Butenedioic acid, 2-[5-chloro-2,4-dioxo-3-(2-propynyl)-1H,3H-pyrimidinyl]-,diethyl ester, (2E)- 0.000463656464354233 0.7284446
NSC 741412 4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one 0.000463656464354233 0.74191279
NSC 747174 Null 0.000463656464354233 0.53594333
NSC 176503 Fastigilin B 0.000463656464354236 0.70671548
NSC 626878 Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride 0.000463656464354236 0.85930681
NSC 600301 Null 0.000568922785167329 0.69760056
NSC 656280 2-Naphthalenemethanaminium, 1,2,3,4-tetrahydro-N,N,N-trimethyl-1-oxo-, iodide 0.00056892278516733 0.7305029
NSC 200692 Aspiculamycin hydrochloride 0.000610795106687072 -0.37864352
NSC 651590 ANTINEOPLASTIC-651590 0.000610795106687072 0.80664801
NSC 662383 2-Bromo-5,8-dihydroxy-3-methyl-1,4-naphthoquinone 0.000610795106687072 0.77842188
Total:138  Current:6    [First] [Prev] [Next] [Last]